Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-257.87%
operating margin TTM
-256.63%
revenue TTM
207.02 Million
revenue per share TTM
0.99$
valuation ratios | |
|---|---|
| pe ratio | -1.47 |
| peg ratio | -0.03 |
| price to book ratio | 5.08 |
| price to sales ratio | 3.80 |
| enterprise value multiple | -1.68 |
| price fair value | 5.08 |
profitability ratios | |
|---|---|
| gross profit margin | 84.55% |
| operating profit margin | -256.63% |
| pretax profit margin | -257.89% |
| net profit margin | -257.87% |
| return on assets | -121.19% |
| return on equity | -266.47% |
| return on capital employed | -197.05% |
liquidity ratio | |
|---|---|
| current ratio | 1.35 |
| quick ratio | 1.35 |
| cash ratio | 0.91 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 73.26 |
| days of payables outstanding | 893.91 |
| cash conversion cycle | -820.65 |
| receivables turnover | 4.98 |
| payables turnover | 0.41 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.71 |
| long term debt to capitalization | 0.41 |
| total debt to capitalization | 0.41 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -4.12 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.56 |
| cash per share | 0.19 |
| operating cash flow per share | -0.55 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -4.12 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -41.04 |
Frequently Asked Questions
When was the last time Sangamo Therapeutics, Inc. (NASDAQ:SGMO) reported earnings?
Sangamo Therapeutics, Inc. (SGMO) published its most recent earnings results on 12-11-2024.
What is Sangamo Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sangamo Therapeutics, Inc. (NASDAQ:SGMO)'s trailing twelve months ROE is -266.47%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sangamo Therapeutics, Inc. (SGMO) currently has a ROA of -121.19%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SGMO's net profit margin stand at?
SGMO reported a profit margin of -257.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SGMO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.35 in the most recent quarter. The quick ratio stood at 1.35, with a Debt/Eq ratio of 0.71.